[HTML][HTML] Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

…, SM Mousavi, S Mukhopadhyay, JB Nachega… - The lancet, 2020 - thelancet.com
Background Health system planning requires careful assessment of chronic kidney disease
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-…

[HTML][HTML] Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts

…, ANH Bulabula, NA Sam-Agudu, JB Nachega… - International journal of …, 2021 - Elsevier
The October 2020 Global TB report reviews TB control strategies and United Nations (UN)
targets set in the political declaration at the September 2018 UN General Assembly high-level …

[HTML][HTML] The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states

…, H Huang, I Martopullo, JA Singh, JB Nachega… - Jama, 2018 - jamanetwork.com
Introduction Several studies have measured health outcomes in the United States, but none
have provided a comprehensive assessment of patterns of health by state. Objective To use …

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

EJ Mills, JB Nachega, I Buchan, J Orbinski, A Attaran… - Jama, 2006 - jamanetwork.com
ContextAdherence to antiretroviral therapy is a powerful predictor of survival for individuals
living with human immunodeficiency virus (HIV) and AIDS. Concerns about incomplete …

[HTML][HTML] Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

…, JB Nachega, DR Bangsberg, S Singh, B Rachlis… - PLoS …, 2006 - journals.plos.org
Background Adherence to highly active antiretroviral therapy (HAART) medication is the
greatest patient-enabled predictor of treatment success and mortality for those who have access …

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International …

…, RH Remien, JM Simoni, JB Nachega - Annals of internal …, 2012 - acpjournals.org
Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care
are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is …

[HTML][HTML] The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017

…, S Mohammed, AH Mokdad, JB Nachega… - The Lancet Infectious …, 2019 - thelancet.com
Background Efforts to quantify the global burden of enteric fever are valuable for understanding
the health lost and the large-scale spatial distribution of the disease. We present the …

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis

JB Nachega, OA Uthman, J Anderson, K Peltzer… - Aids, 2012 - journals.lww.com
… Correspondence to Jean B. Nachega, MD, PhD, Department of International Health, Global
Disease Epidemiology and Control Program, Johns Hopkins University Bloomberg School of …

Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa

JB Nachega, M Hislop, H Nguyen… - JAIDS Journal of …, 2009 - journals.lww.com
… In addition, the following data were also recorded at each prespecified time point: (a) pharmacy
refill adherence to that point and (b) last available post-ART viral load measurement. We …

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda

…, K Chan, N Ford, CL Cooper, JB Nachega… - Annals of internal …, 2011 - acpjournals.org
Background: Little is known about the effect of combination antiretroviral therapy (cART) on
life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once …